A close-up shot of various types of medicines on a table, illustrating the specialty and generic products offered by the ...
Teva reported fourth-quarter revenue of $4.2 billion, beating analyst estimates of $4.13 billion, according to Benzinga Pro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback